Per2 Mutation Recapitulates the Vascular Phenotype of Diabetes in the Retina and Bone Marrow

  1. Maria B. Grant1
  1. 1Department of Pharmacology and Therapeutics, University of Florida, Gainesville, Florida
  2. 2Department of Anatomy and Cell Biology, University of Florida, Gainesville, Florida
  3. 3Department of Physiology, Michigan State University, East Lansing, Michigan
  4. 4Biomedical Sciences Department, Florida State University, Tallahassee, Florida
  1. Corresponding author: Maria B. Grant, grantma@.ufl.edu.

Abstract

In this study, we assessed whether Per2 clock gene–mutant mice exhibit a vascular phenotype similar to diabetes. Per2 (B6.129-Per2tm1Drw/J) or wild-type control mice 4 and 12 months of age were used. To evaluate diabetes-like phenotype in Per2 mutant mice, retina was quantified for mRNA expression, and degree of diabetic retinopathy was evaluated. Bone marrow neuropathy was studied by staining femurs for tyrosine hydroxylase (TH) and neurofilament 200 (NF-200). The rate of proliferation and quantification of bone marrow progenitor cells (BMPCs) was performed, and a threefold decrease in proliferation and 50% reduction in nitric oxide levels were observed in Per2 mutant mice. TH-positive nerve processes and NF-200 staining were reduced in Per2 mutant mice. Both retinal protein and mRNA expression of endothelial nitric oxide synthase were decreased by twofold. Other endothelial function genes (VEGFR2, VEGFR1) were downregulated (1.5–2-fold) in Per2 mutant retinas, whereas there was an upregulation of profibrotic pathway mediated by transforming growth factor-β1. Our studies suggest that Per2 mutant mice recapitulate key aspects of diabetes without the metabolic abnormalities, including retinal vascular damage, neuronal loss in the bone marrow, and diminished BMPC function.

Footnotes

  • Received February 17, 2012.
  • Accepted July 16, 2012.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

| Table of Contents

This Article

  1. Diabetes vol. 62 no. 1 273-282
  1. Supplementary Data
  2. All Versions of this Article:
    1. db12-0172v1
    2. 62/1/273 most recent